Galbiati C 1

1. Continuous vs Intermittent Meropenem Administration in Critically Ill Patients with Sepsis: The MERCY Randomized Clinical Trial
2. High dose esomeprazole as an anti-inflammatory agent in sepsis: Protocol for a randomized controlled trial
1